A Study of Mirikizumab (LY3074828) in Healthy Participants
Clinical trial NCT02568423 · COMPLETED
Trial details
- NCT number
- NCT02568423
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-02
- Primary completion
- 2018-07-16
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.